Northwest Biotherapeutics: All Is Not Well With This One [Seeking Alpha]
NORTHWEST BIOTHRPUTCS INC (NWBO)
US:NASDAQ Investor Relations:
nwbio.com/investors-media
Company Research
Source: Seeking Alpha
1.71K Follower s Follow Summary Northwest Bio is sitting near 5-year lows, but they have accomplished a key goal in getting their product submitted for approval. The company's near-term prospects hinge on DCVax, a dendritic cell vaccine aimed at generating a tailored immune response by using a patient's own immune cells. Despite mixed opinions on the validity of their phase 3 trial published in January 2023, the potential of DCVax remains a focal point for investors. With almost no cash on hand, the company is funding itself through a shoestring effort, but no word on how they will definitively address cash issues. Approval is still possible, even though the review is taking longer than the company would like; there has not been guidance from them on the status of this application. CasarsaGuru/E+ via Getty Images Topline Summary and Update Northwest Biotherapeutics ( OTCQB:NWBO ) is one of those never-say-die companies that just keeps hanging in there despite what
Show less
Read more
Impact Snapshot
Event Time:
NWBO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NWBO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NWBO alerts
High impacting NORTHWEST BIOTHRPUTCS INC news events
Weekly update
A roundup of the hottest topics
NWBO
Sec Filings
- 11/12/24 - Form 10-Q
- 11/1/24 - Form 8-K
- NWBO's page on the SEC website